IRVINE, Calif., and LITTLE FALLS, N.J., June 13 /PRNewswire/ -- Relsys International, the leading provider of software solutions for adverse event reporting, pharmacovigilance and risk management, announced today that it has extended its partnership with Sentrx, a leading provider of technology-enabled services for global drug safety, to host Relsys' Argus Safety(TM) solution. The hosted model provides an opportunity for smaller organizations to meet their drug safety commitments. Nearly twenty pharmaceutical and biotechnology companies are already realizing the benefits of this partnership.

"Relsys International has been offering value-added solutions to the life science industry for more than twenty years. This joint offering is another example Relsys' commitment to addressing the industry's drug safety, pharmacovigilance and risk management needs," said John Loucks, Relsys' Chief Customer Officer. "Sentrx is a valuable partner for us as we reach out to organizations of all sizes, including those that currently lack the scale to deploy an in-house solution."

"Sentrx has invested more than one million dollars in its Managed Safety System Hosting Center and has become an industry expert at implementing, configuring, validating and supporting Argus Safety(TM) over the past six years," said Joseph Albano, Chief Executive Officer of Sentrx. "We remain committed to organizations that choose to outsource their drug safety systems and adverse event case processing and appreciate Relsys'confidence in our offerings."

Argus Safety(TM) is the industry-leading safety solution, with more licensed users than any other drug safety product. The web-based application ensures regulatory compliance and yields significantly greater productivity by streamlining business process workflow.

Relsys will be showcasing Argus Safety(TM) as well as Argus Perceptive(TM), its ground-breaking signal detection technology, at the DIA Annual Meeting in Atlanta, GA at Booth 1127. Sentrx will be exhibiting its drug safety solutions at Booth 1644.

About Relsys International Relsys International provides the industry-leading Argus suite, a complete systems solution for pharmacovigilance and risk management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients' corporate risk management strategies. Argus Safety(TM), the company's flagship product, is the world's best-selling adverse event reporting software, and is used by more of the leading pharmaceutical companies than any other solution. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit http://www.relsys.net, or call +1 949-453-1715.

About Sentrx
Sentrx is a leading provider of technology-enabled solutions and services for global drug safety. Its mission is to help pharmaceutical, biotechnology, medical device, and consumer health companies document the safety profile of their products during clinical development and postapproval, enabling them to minimize risks and maximize benefits. Through its multilingual Safety Response Center, Sentrx delivers a unique combination of highly skilled people, exclusive technology, and best practices in drug safety monitoring. To learn more about Sentrx, please visit their website at www.sentrx.com, or call 1-888-399-8032, extension 261.